The Latest Analyst Ratings for Replimune Group
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 9 analysts have published their opinion on Replimune Group (NASDAQ:REPL) stock. The average price target is $54.11, implying an upside from the current price of $21.12. The majority of the ratings are bullish, with 6 out of 9 analysts giving a positive outlook.
August 04, 2023 | 9:21 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have a bullish outlook on Replimune Group, with a majority giving a positive rating. The average price target indicates a potential upside.
The bullish outlook from analysts suggests a positive sentiment towards the stock. The average price target, which is significantly higher than the current price, indicates a potential upside. This could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100